Breast Cancer

MIT Radar Technology Enters Phase II Trials

Published in Cancer Weekly, January 16th, 2001

An Massachusetts Institute of Technology (MIT) researcher's work on radar technology to detect missiles will be applied in U.S. Food and Drug Administration (FDA)-approved Phase II clinical trials for the treatment of breast cancer.

A Phase I clinical trial was completed in July 2000. In the Phase II trials, more than 100 women will receive focused microwave thermotherapy to heat breast cancer cells to about 115 degrees Fahrenheit, killing them.

"This is an out-patient procedure. Patients treated in the Phase I trial went home with only one or two tiny band aids," said Alan J. Fenn, senior staff member in the Air Defense Technology Division at...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2001-01-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry